Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab Exposure.

Acta gastro-enterologica Belgica·2025
Same author

Bismuth-based quadruple therapy versus standard triple therapy for the eradication of Helicobacter pylori in Belgium: a multicentre, non-blinded randomized, prospective study.

Acta gastro-enterologica Belgica·2024
Same author

Belgian consensus for Helicobacter pylori management 2023.

Acta gastro-enterologica Belgica·2023
Same author

Oral tuberculosis in a patient with Crohn's disease on TNF-α blockers.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Ulcerative colitis treatment : an insight into daily clinical practice.

Acta gastro-enterologica Belgica·2019
Same author

Transluminal removal of a giant fibrovascular polyp of the esophagus.

Acta gastro-enterologica Belgica·2019
Same journal

A rare twist in the abdomen: diagnostic and therapeutic approaches to omental infarction - a case report and literature review.

Acta gastro-enterologica Belgica·2026
Same journal

GLP-1 receptor agonist-associated eosinophilic duodenitis presenting as a bowel obstruction : a case report and literature review.

Acta gastro-enterologica Belgica·2026
Same journal

Ampullary Actinomycosis Mimicking Malignancy: A Case Report and Literature Review.

Acta gastro-enterologica Belgica·2026
Same journal

Recurrent gastrointestinal bleeding after Peptide Receptor Radionuclide Therapy for a small intestine neuroendocrine tumor.

Acta gastro-enterologica Belgica·2026
Same journal

A little known cause of ischemic colitis.

Acta gastro-enterologica Belgica·2026
Same journal

Linaclotide for irritable bowel syndrome with constipation: integrating realworld evidence into the therapeutic puzzle.

Acta gastro-enterologica Belgica·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2026

Cryo-EM and Single-Particle Analysis with Scipion
09:06

Cryo-EM and Single-Particle Analysis with Scipion

Published on: May 29, 2021

The Maastricht III consensus: summary and comments.

F Mana1

  • 1Department of Gastroenterology, UZBrussel, Brussels, Belgium. gasmaf@uzbrussel.be

Acta Gastro-Enterologica Belgica
|November 12, 2009
PubMed
Summary
This summary is machine-generated.

New guidelines update Helicobacter pylori infection management, adding new treatment indications and emphasizing early intervention for gastric cancer prevention. Rising clarithromycin resistance necessitates exploring alternative therapies.

Related Experiment Videos

Last Updated: Jun 18, 2026

Cryo-EM and Single-Particle Analysis with Scipion
09:06

Cryo-EM and Single-Particle Analysis with Scipion

Published on: May 29, 2021

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Oncology

Background:

  • Helicobacter pylori infection management has been updated based on recent findings.
  • New guidelines were published in 2007 in the journal Gut.
  • The study highlights the link between H. pylori and gastric cancer prevention.

Purpose of the Study:

  • To review updated guidelines for Helicobacter pylori infection management.
  • To discuss the role of H. pylori treatment in gastric cancer prevention.
  • To address the challenge of increasing antibiotic resistance in H. pylori treatment.

Main Methods:

  • Review of the 2007 Gut guidelines for H. pylori management.
  • Analysis of indications for H. pylori treatment, including new additions.
  • Examination of H. pylori treatment strategies in light of antibiotic resistance.

Main Results:

  • New indications for H. pylori treatment include iron deficiency anemia and idiopathic thrombocytopenic purpura.
  • Early treatment of H. pylori is crucial for preventing gastric cancer, especially before premalignant lesions develop.
  • Increasing resistance to clarithromycin is reducing the efficacy of standard H. pylori therapies.

Conclusions:

  • Updated guidelines provide a framework for H. pylori management, incorporating new indications and emphasizing gastric cancer prevention.
  • The growing resistance to clarithromycin poses a significant challenge, requiring the exploration of alternative antibiotic treatments.
  • Understanding regional antibiotic resistance patterns, such as those in Belgium, is vital for effective H. pylori eradication strategies.